CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-16 | Swayze Eric EVP Research | Sale | −53 | $43.54 | $2K | 390 |
| 2026-10-15 | Swayze Eric EVP Research | Exercise or conversion | +125 | 443 | ||
| 2026-10-15 | Swayze Eric EVP Research | Exercise or conversion · Restricted Stock Unit | −125 | 486 | ||
| 2026-06-25 | Swayze Eric EVP Research | Sale 10b5-1 | −10,602 | $79.18 | $839K | 21,759 |
| 2026-02-27 | Swayze Eric EVP Research | Other acquisition | +256 | $48.87 | $13K | 32,361 |
| 2026-02-13 | Swayze Eric EVP Research | Sale 10b5-1 | −9,435 | $81.56 | $770K | 38,312 |
| 2026-02-13 | Swayze Eric EVP Research | Sale 10b5-1 | −6,207 | $82.07 | $509K | 32,105 |
| 2026-01-30 | Swayze Eric EVP Research | Sale | −6,179 | $82.93 | $512K | 47,747 |
| 2026-01-29 | Swayze Eric EVP Research | Grant or award | +11,991 | 53,926 | ||
| 2026-01-16 | Swayze Eric EVP Research | Sale | −9,884 | $75.34 | $745K | 41,935 |
| 2026-01-16 | Swayze Eric EVP Research | Sale | −49 | $75.97 | $4K | 318 |
| 2026-01-15 | Swayze Eric EVP Research | Exercise or conversion | +21,366 | 51,819 | ||
| 2026-01-15 | Swayze Eric EVP Research | Exercise or conversion | +111 | 367 | ||
| 2026-01-15 | Swayze Eric EVP Research | Grant or award · Performance Restricted Stock Units | +25,800 | 90,282 | ||
| 2026-01-15 | Swayze Eric EVP Research | Exercise or conversion · Restricted Stock Unit | −21,366 | 39,251 | ||
| 2026-01-15 | Swayze Eric EVP Research | Grant or award · Restricted Stock Unit | +9,675 | 48,926 | ||
| 2026-01-15 | Swayze Eric EVP Research | Exercise or conversion · Restricted Stock Unit | −111 | 386 | ||
| 2026-01-15 | Swayze Eric EVP Research | Grant or award · Restricted Stock Unit | +225 | 611 | ||
| 2026-01-02 | Swayze Eric EVP Research | Exercise or conversion 10b5-1 | +5,125 | $60.89 | $312K | 35,578 |
| 2026-01-02 | Swayze Eric EVP Research | Sale 10b5-1 | −5,125 | $78.57 | $403K | 30,453 |
Page 1 of 3 · 50 trades